Results 221 to 230 of about 17,612,218 (346)

137 Stage I and II follicular lymphoma: Longterm outcome and pattern of failure following treatment with involved field radiation therapy alone

, 1999
M.K. Gospodarowicz, T. Lippuner, Melania Pintilie, Bruce Patterson, Andrea Bezjak, Richard Tsang, Woodrow Wells   +6 more
openalex   +1 more source

Early Discontinuation of Treatment in Children with Uncomplicated Epilepsy: A Prospective Study with a Model for Prediction of Outcome [PDF]

, 1997
Gunnar Braathen, Hans Melander
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Use machine learning to predict treatment outcome of early childhood caries. [PDF]

BMC Oral Health
Wu Y, Jia M, Fang Y, Duangthip D, Chu CH, Gao SS.   +5 more
europepmc   +1 more source

Alcoholism treatment outcome studies, 1980–1992: The nature of the research

, 1996
Anthony S. Floyd, Susanne C. Monahan, John W. Finney, Jeanne A. Morley   +3 more
openalex   +1 more source

Induction of the Antigen 85 Complex ofMycobacterium tuberculosisin Sputum: A Determinant of Outcome in Pulmonary Tuberculosis Treatment [PDF]

, 1998
Robert S. Wallis, Mark D. Perkins, Manijeh Phillips, Moses Joloba, Barbara S. Demchuk, Alice Namale, John L. Johnson, Donna M. Williams, Kathy Wolski, Luciléia Teixeira, Reynaldo Dietze, Roy D. Mugerwa, Kathleen D. Eisenach, Jerrold J. Ellner   +13 more
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Gambling disorder and problematic pornography use: Does co-occurrence influence treatment outcome? [PDF]

J Behav Addict
Mestre-Bach G, Potenza MN, Granero R, Håkansson A, Gómez-Peña M, Perales I, Vicó À, Uríszar JC, Fernández-Aranda F, Sánchez I, Jiménez-Murcia S.   +10 more
europepmc   +1 more source

Avoiding nocebo effects to optimize treatment outcome.

Journal of the American Medical Association (JAMA), 2014
U. Bingel
semanticscholar   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source